This Week in Psychedelics - 2.26.21

Cannabis

• Murphy signs N.J. legal weed bills, ending 3-year saga (NJ.com)

• North Dakota House votes to legalize recreational marijuana (KXNet.com)

• Alabama Senate passes medical marijuana legislation (WTVM)

• South Dakota: House Members Approve Legislation to Delay Implementation of Voter-Approved Medical Cannabis Law (NORML)

• Virginia OKs smokable flower in move that could spur medical marijuana sales (Marijuana Business Daily)

• Marijuana legalization passes in Minnesota House Committee vote (KIMT)

• Cannabis legalization bill headed to House floor (Albuquerque Journal)

• FDA to include cannabis on essential drugs list (Bangkok Post)

• Virginia Conference Committee Faces Saturday Deadline To Finalize Marijuana Legalization Proposal (Marijuana Moment)

• Pa. lawmakers introduce bipartisan bill to legalize recreational marijuana (WHTM)

• Marijuana legalization proposed in Maryland Legislature (The Washington Post)

• Kansas Governor’s Medical Marijuana Bill Introduced As Lawmakers Take Up Separate Legalization Proposal (Marijuana Moment)

• Colorado families ask for statewide school cannabis access (The Colorado Sun)

• Study: Enactment of Marijuana Legalization Laws Associated with Reductions in Opioid Prescribing Patterns (NORML)

• Legal Marijuana States See Reduced Workers’ Compensation Claims, New Study Finds (Marijuana Moment)

• Missouri pushes back deadline for medical cannabis businesses to open (Marijuana Business Daily)

• Study: Cannabis Mitigates Symptoms in Patients with Treatment-Resistant Fibromyalgia (NORML)

• South Carolina Voters Support Legalizing Medical Marijuana By A Five-To-One Ratio, New Poll Finds (Marijuana Moment)

Magic Mushrooms

• Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director (Psilocybin Alpha)

• Penis Envy Mushrooms: Murder & Conspiracy Behind the World’s Trippiest Shroom (DoubleBlind)

• Red Light Holland, the First Public Candian Psychedelics Company, Is Ready To Sell You Magic Truffles (Lucid News)

MDMA

• MDMA proves a promising alcoholism treatment in world-first trial (New Atlas)

• The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy (Psychedelic Science Review)

• Root Beer and MDMA: Degrees of Separation (Truffle Report)

DMT

• PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy (Psilocybin Alpha)

• The Ultimate Guide to DMT Pricing (Reality Sandwich)

Iboga

• Ibogaine Addiction Therapy: Then and Now (Truffle Report)

Morning Glory Seeds

• Microdosing LSA: People are Microdosing Acid’s Less Known, Legal Cousin (DoubleBlind)

Synthetic Cannabinoids

• Synthetic cannabis: an unknown gamble with potentially fatal consequences (Stuff.co.nz)

Ketamine

• Elijah McClain's mother relieved he 'is no longer labeled a suspect' after investigation into officers' actions (CNN)

• Aurora, Colorado, to hire independent police monitor after investigation into Elijah McClain's death (KDRV)

• What To Look For When Searching For A Ketamine Clinic (Healing Maps)

PCP

• Rochester police officers involved in suffocation death of Daniel Prude will not face charges (KTLA)

Miscellaneous

• Norway seeks to decriminalise recreational drug use (RTÉ)

• Vermont Introduces Bill to Decriminalize Entheogenic Plants (Truffle Report)

• NYU Langone Health Establishes Center for Psychedelic Medicine (NYU Langone Health)

• Missouri Bill Would Add MDMA, Psilocybin Mushrooms And LSD To Right-To-Try Law (Marijuana Moment)

• Psychedelic Therapy Needs to Confront the Mystical (VICE)

• After a Year of Controversy, MAPS Canada Executive Director Mark Haden Announces Resignation (Psymposia)

• Washington Supreme Court Strikes Down Criminalization Of Drug Possession (Marijuana Moment)

• Casey William Hardison: A Clandestine Chemist’s View on Cognitive Liberty (Filter)

• Why the US Has Embraced Drug Law Reform, But the UK Won't (VICE)

• The Guardian view on illegal drugs: the laws don’t work (The Guardian)

• An Urgent Plea to Users of Psychedelics: Let’s Consider a More Ethical Menu of Plants and Compounds (Tim Ferriss Blog)

• What If We Pay People to Stop Using Drugs? (The New Republic)

• Alexander "Sasha" Shulgin: A Retrospective (Truffle Report)

• The Farmer and The Cowman Should Be Friends: Why the Pharmaceutical Industry and Grassroots Reformists Should Join Forces (Psychedelics Today)

• Microneedle patches for microdosing psychedelic pharmaceuticals (EurekAlert!)

• Meet the Psychedelic Rapper Running for New York City Mayor (DoubleBlind)

• The Case For Psychedelic Couples Counseling (GQ)

• Love and Psychedelic Psychotherapy: Bridging the Divide (Chacruna)

• How Psychedelics Impact Startle Response (Truffle Report)

• The Problem and Paradox of Bad Trips, Part 2 (Psychedelic Science Review)

• Joe Rogan: Dedemonizing Psychedelics (Reality Sandwich)

• Psychedelics, Capitalism, and the Commodification of the Sacred (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.19.21

Cannabis

• The US cannabis industry now supports 321,000 full-time jobs (Leafly)

• North Dakota Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)

• New Mexico Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)

• Minnesota Marijuana Legalization Bill Approved In First Committee Vote (Marijuana Moment)

• Hawaii Senate Panel Approves Bills To Legalize Marijuana And Increase Decriminalization Limit (Marijuana Moment)

• North Dakota Marijuana Decriminalization Bill Advances As Activists And Lawmakers Push Legalization Measures (Marijuana Moment)

• New Jersey Lawmakers’ Marijuana Talks Break Down Months After Voters Approve Legalization (Marijuana Moment)

• New York Governor To Send Amended Marijuana Legalization Plan To Lawmakers Amid Criticism (Marijuana Moment)

• Cannabis spurs creative but unrealistic ideas, study shows (Marijuana Business Daily)

• Maryland Lawmakers Push To Legalize Marijuana And Expunge Convictions (High Times)

• South Dakota rejects telemedicine for medical marijuana consultations (Marijuana Business Daily)

• Medical cannabis dependence: A critical review of issues and evidence (Drug Science)

• Cannabis mixtures studied as treatment for COVID inflammation (Marijuana Business Daily)

• Study: Adult-Use Marijuana Legalization Laws Associated with Declines in Workers’ Compensation Claims (NORML)

• NFL Explores How Marijuana And CBD Can Be Used As Opioid Alternatives For Players (Marijuana Moment)

• ‘Increasingly potent’: Do you have the heart to smoke marijuana? (The Independent)

• DEA Wants To Know About Applicants’ Hemp And CBD Use, But Only Pre-Legalization (Marijuana Moment)

• Cannabis Inhalation Associated with Clinical Improvement in Patients with Ulcerative Colitis (NORML)

• Cannabinoids can improve skin, study says (Marijuana Business Daily)

LSD

• MindMed’s LSD Neutralizer Study Begins (Psilocybin Alpha)

• Cary Grant Took LSD Every Day For 10 Years, According to an Ex-Wife (Showbiz Cheat Sheet)

Magic Mushrooms

• New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain (UC San Diego Health)

• California Activists Gear Up For 2022 Push To Legalize Psilocybin Mushrooms (Marijuana Moment)

• Researchers Demand Reparations to Mazatecs for Mushroom “Spirit” (Chacruna)

• Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders (Psilocybin Alpha)

• Silo Wellness expands mushroom efforts in Jamaica (Jamaica Observer)

• PharmaTher Announces Sale of Psilocybin Program (Psilocybin Alpha)

• Blue Goba Goes Down Temporarily (Psillow)

• From Magic Mushroom to Forbidden Fungus (and Back) (Reason)

MDMA

• Mind Medicine Australia challenges TGA Interim Decision (Mind Medicine Australia)

• Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation (Psilocybin Alpha)

Ayahuasca

• Rapid antidepressant effects of the psychedelic ayahuasca linked to changes in inflammatory biomarkers (PsyPost)

• Ayahuasca Could Help With Grief (Truffle Report)

5-MeO-DMT

• Jaguar (5-MeO-DMT) Vape Pens (Erowid)

Iboga

• Comparing 18-MC vs. Ibogaine for the Treatment of Substance Use Disorder (Psychedelics Today)

• The Bwiti Religion and Iboga Root (Truffle Report)

• Ibogaine, Then and Now (The Third Wave)

Novel Psychoactive Substances

• The Structure-Activity Relationship of Psilocybin Analogs (Psychedelic Science Review)

Ketamine

• The Nuances of Ketamine’s Neurochemistry (Psychedelic Science Review)

• Off and on: Elijah McClain ketamine investigation now on hold at state health department (KDVR)

Miscellaneous

• California bill would decriminalize psychedelics, paving the way for medical treatment (The Guardian)

• GOP Iowa Lawmaker Files Bill To Allow Psilocybin, MDMA And LSD Access For Seriously Ill Patients (Marijuana Moment)

• Envisioning a psychedelic future for Philadelphia’s USciences as it pairs with Compass Pathways for a Drug Discovery Center (The Philadelphia Inquirer)

• Washington Lawmakers Approve Drug Decriminalization Bill In Committee Vote (Marijuana Moment)

• Vermont Lawmakers Prepare Psychedelics And Broader Drug Decriminalization Bills For Introduction (Marijuana Moment)

• Will the Federal Government Finally Embrace the Psychedelic Revolution? (Rolling Stone)

• ATMA Launches Canada's First Psychedelic Training Program for Mental Health Professionals that Includes a Legal Psychedelic Experience (Cision)

• The Faux Shamanism of Jake “Angeli” Chansley (Lucid News)

• Could the Embrace of Psychedelics Lead to a Mental-Health Revolution? (Vogue)

• Cocaine, cannabis or ecstasy – whatever your drug, it has an impact on the planet (The Independent)

• The Psychedelic Stock Liftoff. Why Psychedelics over Cannabis? (Dark Matters)

• Current Psychedelic Research Lacks Diversity (Volteface)

• Psychedelics in the Age of Sexual Liberation (The Oak Tree Review)

• Celebrating 25 Weeks of ‘Women in the History of Psychedelic Plant Medicines’ (Chacruna)

• Microdosing for Chronic Pain: Does it Actually Help? (DoubleBlind)

• The Problem and Paradox of Bad Trips – Part 1 (Psychedelic Science Review)

• Orientation Before Preparation (Psychedelic Frontier)

• Future Generations Will Condemn the Drug War: Reform Is Urgent and Inevitable (Sydney Criminal Lawyers)

• Will Health Insurance Ever Cover Psychedelic-Assisted Therapies? (Truffle Report)

• Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in a New Era of Hope to Deal with the Growing Mental Health Crisis in Canada (Psilocybin Alpha)

• Psychedelics and the Queer Art of Survival (Chacruna)

• Why Psychedelics Are a More 'Compassionate' Way to Treat Trauma (Inverse)

• Jade Ullmann is Bridging Together Psychedelic Communities (Lucid News)

• From trippy drugs to therapeutic aids – how psychedelics got their groove back (The Conversation)

• Rise In Consumer Acceptance of Psychedelic Drug Therapies Is Quickly Increasing (PR Newswire)

• Could Psychedelic-Assisted Therapy Help Treat Bipolar II Disorder? (Truffle Report)

• How Psychedelics Can Help Treat Anxiety (Psychedelic Passage)

• 'Could we treat depression by prescribing patients a psychedelic drug?' (Mirror)

• A therapist explains what it’s like to give psychedelic-assisted therapy. (Inverse)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.12.21

Cannabis

• Virginia lawmakers vote to legalize marijuana (8News)

• Judge rules recreational marijuana measure unconstitutional in South Dakota (Sioux Falls Argus Leader)

• Lax THC vape rules still allow toxins into your lungs (Leafly)

• Idaho Medical Marijuana Activists Approved For Signature Gathering Amid Legislative Complications (Marijuana Moment)

• Jamaica faces marijuana shortage as farmers struggle (AP News)

• Wisconsin: Governor Evers Includes Marijuana Legalization in State Budget Proposal (NORML)

• Connecticut Governor Includes Marijuana Legalization Plan In Budget Proposal (Marijuana Moment)

• South Dakota governor to delay medical cannabis program until 2022 (Marijuana Business Daily)

• The Half-Legal Cannabis Trap (Politico)

• Bipartisan Marijuana Research Bill Reintroduced In The Senate (Marijuana Moment)

• Poll: 61 Percent of US Adults Say Marijuana Legalization Is a “Good Idea” (NORML)

• Medical cannabis law has been left in a haze (The Times)

• New weed group tries to unify disparate cannabis factions (Politico)

• TV Show Host and Travel Author Rick Steves to Chair NORML Board of Directors (NORML)

• Mississippi Senate Approves Alternate Medical Marijuana Program, Hours After Defeating It (Marijuana Moment)

• Weed Could Make Dogs Less Aggressive to Humans (VICE)

• Starting A Business? Study Finds Marijuana May Help—And Hinder (Marijuana Moment)

• Poll: Majority of North Carolina Voters Support Marijuana Legalization (NORML)

LSD

• Software engineer in Bodega Bay LSD rampage allowed to serve one-year jail term at home (Santa Rosa Press Democrat)

• The reason why George Harrison gave up using LSD (Far Out Magazine)

Magic Mushrooms

• Texas Would Study Psilocybin And MDMA To Treat PTSD And Depression Under New Bill (Marijuana Moment)

• Iowa GOP Lawmaker Makes Another Push To Decriminalize Psilocybin Mushrooms (Marijuana Moment)

• New nonprofit aims to advise on creation of Oregon’s psilocybin-assisted therapy system (OPB)

• Hackers, Mason Jars, and the Psychedelic Science of DIY Shrooms (WIRED)

• Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study (Psilocybin Alpha)

• Nova Mentis Psilocybin Approved for Shipment to Italy (Psilocybin Alpha)

MDMA

• The Role of Oxytocin in MDMA’s Prosocial Effects (Psychedelic Science Review)

DMT

• DMT for Depression: Paving the Way for New Medicine (Reality Sandwich)

• PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke (Psilocybin Alpha)

5-MeO-DMT

• Conservationists Plead With Public to Stop Milking Psychedelic Toads (Euronews)

Mescaline

• Mescaline Scribe (Chacruna)

Peyote

• Blessings of Life and Peyote with Debi Roan (Chacruna)

Novel Psychoactive Substances

• Diagnosing intake of two new psychoactive substances (Medical Xpress)

Ketamine

• Regular oral doses of ketamine significantly reduce suicidal thoughts (New Atlas)

Miscellaneous

• Can a Company Patent the Basic Components of Psychedelic Therapy? (VICE)

• A Biotech Startup Won a Patent to Combine Elements of Weed and Psychedelics (Future Human)

• Self-admitted psychedelic use and association with psychedelic culture harm perceptions of researchers’ scientific integrity (PsyPost)

• New Professional Associations for Medical and Legal Practitioners Emerge for the Psychedelic Space (Lucid News)

• This Weird, Futuristic Helmet Will Let People Scan Their Brains While Tripping (DoubleBlind)

• 20-Year-Old Kansas Lawmaker Files Drug Decriminalization Bill (Marijuana Moment)

• Black People Trip: Meet the Woman Creating Black Psychedelic Community (DoubleBlind)

• MAPS, Fireside Project to Collaborate on Psychedelic Peer Support Line (Psych Congress Network)

• Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica (Psilocybin Alpha)

• The case for mass producing psychedelic pharmaceuticals (Health Europa)

• Psychedelic drug memo sparks uproar (The Australian)

• Turn Off Your Mind, Relax—and Float Right-Wing? (Psymposia)

• 3 Reasons You May Feel Unnecessary Guilt for Using Drugs (Medium)

• Is Social Media the Best Place to Buy Drugs? (DoubleBlind)

• Psychedelic Exploration (Maps of the Mind)

• 10 Questions You Always Wanted to Ask a Psychedelic Lawyer (VICE)

• Psychedelics And Spiritual Emergencies (Healing Maps)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.5.21

Cannabis

• Democratic Senate Leaders Announce Steps To Federally Legalize Marijuana In 2021 (Marijuana Moment)

• Idaho Senate Passes Measure To Block Marijuana Legalization, Even If Voters Approve It On The Ballot (Marijuana Moment)

• Marijuana Legalization Bills Headed to Virginia Senate and House (Filter)

• Top Minnesota Lawmakers File Marijuana Legalization Bill For 2021 (Marijuana Moment)

• New Mexico Senators File Two Marijuana Legalization Bills, With More On The Way (Marijuana Moment)

• Maryland Marijuana Legalization Bill Sponsored By Senate President And Other Top Lawmakers (Marijuana Moment)

• Alabama Senate Committee Approves Medical Marijuana Legalization Bill (Marijuana Moment)

• Sustainability In The Cannabis Industry: Truly Going Green (Forbes)

• Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients (NORML)

• The “Secret Handshake”—A Program Gifting Cannabis to Unhoused People (Filter)

• Adult-Use Marijuana Legalization Not Associated with Any Rise in Substance Abuse Treatment Admissions (NORML)

• Mississippi’s high court to hear arguments to block medical cannabis (Marijuana Business Daily)

• Philadelphia: Marijuana Treatment Admissions Drop Eighty Percent (NORML)

LSD

• Neuroscience study indicates that LSD “frees” brain activity from anatomical constraints (PsyPost)

• Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD (Psilocybin Alpha)

Magic Mushrooms

• New Jersey Governor Signs Psilocybin Bill To Immediately Reduce Penalties For Possession (Marijuana Moment)

• Psychedelic Mushroom Bills Filed In Florida And Connecticut As Movement Expands To Multiple States (Marijuana Moment)

• Federal Judge Decides Against Prison for Denver Mushroom Dealer (Westword)

• Psilocybin and Neurogenesis: The Long-Term Effects of Magic Mushrooms on Your Brain (Entheonation)

• COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy (GlobeNewswire)

MDMA

• MDMA and psilocybin not approved for medicinal use in Australia (9News)

• MDMA-Assisted Therapy is Less Effective if You Take Antidepressants (DoubleBlind)

DMT

• Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule” (Psilocybin Alpha)

• Why Does DMT Pervade Nature? (Reality Sandwich)

Ayahuasca

• The Ancestral Healing Power of Ayahuasca (Psychedelic Science Review)

5-MeO-DMT

• Psychedelic Toads Pushed To The Limit, Conservationists Urge Synthetic 5-MeO-DMT Option (Forbes)

Novel Psychoactive Substances

• Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies (Psilocybin Alpha)

Nitrous Oxide

• Nitrous Nation (The New York Times)

Ketamine

• Proposed law could bar SC 1st responders from using ketamine to incapacitate suspects (The Post and Courier)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine (Psilocybin Alpha)

• PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease (Psilocybin Alpha)

• Psychedelic Wellness-Focused Company Delic to Acquire Ketamine Infusion Centers LLC (PR Newswire)

• Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas (BioSpace)

Miscellaneous

• Drug Decriminalization Goes Into Effect in Oregon (Rolling Stone)

• Cambridge City Council Decriminalizes Psychedelics And Urges Police To End Drug Arrests More Broadly (Marijuana Moment)

• Washington Lawmakers Introduce Long-Awaited Bill To Decriminalize All Drugs And Expand Treatment (Marijuana Moment)

• Mass General Launches New Center to Study Psychedelics in Psychiatry (Massachusetts General Hospital)

• Psychedelics as Antidepressants (Scientific American)

• Health Canada considers amending Special Access Program (Psillow)

• QAnon shaman turns against Trump, says he would testify that president incited Capitol riots (National Post)

• Biden Quietly Announces Harm Reduction Among His Drug Priorities (Filter)

• Timothy Leary’s Castalia Foundation Has Been Co-opted to Promote Conspiracy Theories about COVID and Elite Pedophile Rings (Psymposia)

• Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board (Psilocybin Alpha)

• Neuroscience students launch Psychedelic Society (The Glasgow Guardian)

• Pharmacological Testing in Psychedelic Research (Psychedelic Science Review)

• How To Setup Music for Psychedelic Sessions (+ 6 More Playlists for Psilocybin) (Maps of the Mind)

• Marlene Dobkin de Rios: A Case for Complex Histories of Women in Psychedelics (Chacruna)

• Is Microdosing Psychedelics the Secret to Sobriety? (MEL Magazine)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.29.21

Cannabis

• Arizona: Adult Use Marijuana Sales Begin (NORML)

• 2 Years After Legalizing Cannabis, Has Canada Kept Its Promises? (The New York Times)

• Alabama Could Legalize Medical Marijuana Under Bill Filed By Republican Senator (Marijuana Moment)

• CBD Destroys Antibiotic-Resistant Bacteria Such as Gonorrhea, Study Finds (VICE)

• Chuck Schumer Lists Marijuana As A Priority In First Post-Election Cannabis Comments (Marijuana Moment)

• Anti-Marijuana Lawmaker Files Legalization Bill In North Dakota To Avoid Activist Ballot Measure (Marijuana Moment)

• Areas With More Marijuana Dispensaries Have Fewer Opioid Deaths, New Study Finds (Marijuana Moment)

• Opioid Prescriptions Decline in Canada Following Enactment of Adult-Use Marijuana Legalization (NORML)

• Transition From Trump To Biden Impacts Federal Hemp And CBD Rules (Marijuana Moment)

• Michigan testing labs sound warning about contaminated cannabis (Marijuana Business Daily)

• Bill To Allow Medical Marijuana Use At Hotels And Airbnbs Filed In Missouri (Marijuana Moment)

LSD

• LSD breakthrough could enable treatment for autism and social anxiety, research finds (Sky News)

Magic Mushrooms

• Hawaii Could Legalize Psychedelic Mushroom Therapy Under New Senate Bill (Marijuana Moment)

• Kevin Matthews Wants to Decriminalize Mushrooms Across Colorado (Westword)

• Port Townsend woman seeks decriminalization of ‘magic’ mushrooms (Peninsula Daily News)

• UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition (Psilocybin Alpha)

• Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility (Psilocybin Alpha)

• Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland (Psilocybin Alpha)

• MagicMed Files For Psilocybin Derived Patents (Green Market Report)

• Is America Ready For Psilocybin Mushroom Retreats? (Benzinga)

MDMA

• Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon (The Conversation)

DMT

• Having Sex on DMT: What You Need to Know (Reality Sandwich)

Ayahuasca

• Ayahuasca, Severe Illnesses, and the Mystery of Death (Chacruna)

• Woman, 29, killed herself after ‘suffering psychosis from taking hallucinogenic yoga drugs on spiritual retreat’ (The Sun)

• Ayahuasca’s Role in the Entourage Effect and Depression (Psychedelic Science Review)

• An Ayahuasca Retreat Brings Powerful Changes (Healing Maps)

Peyote

• Let’s Talk About Hikuri: A Peyote Conservation Project by the Wixárika (Chacruna)

Iboga

• How the psychedelic Ibogaine helped a retired Vancouver firefighter treat his depression (The GrowthOp)

Novel Psychoactive Substances

• BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies (Psilocybin Alpha)

Ketamine

• Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression (Psilocybin Alpha)

• Ketamine to treat depression and addiction at UK’s first medical psychedelic psychotherapy clinic (iNews)

• Users of ketamine at significantly higher risk of suicide: study (Focus Taiwan)

• A Wall Street banker who made millions in the dot com boom dropped it all to become a 'psychedelics concierge' to the stars. Now he wants everyone to have access to ketamine. (Insider)

• How to Know if Ketamine Therapy Is Right for You (Santa Clarita Magazine)

DXM

• Low-dose dextromethorphan for the treatment of fibromyalgia pain: results from a longitudinal, single-blind, placebo-controlled pilot trial (MD Linx)

Miscellaneous

• New Psychedelics Reform Group Sets Sights On Congress As Movement Builds (Marijuana Moment)

• Atlanta: Mayor Takes Executive Action Abolishing Pre-Employment Drug Screens for Many Public Employees (NORML)

• The Latest on Psychedelics for Treating Dementia (Psychedelic Science Review)

• The world's first psychedelic ETF debuts (Yahoo! Finance)

• Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US (Psilocybin Alpha)

• The Cop Who Busted the Beatles Now Wants to Legalise All Drugs (VICE)

• When The Giants Of Indian Classical Music Collided With Psychedelic San Francisco (NPR)

• Mydecine Innovations Group Files Application to list to the NASDAQ (Psilocybin Alpha)

• Biden Ending Federal Contracts With Private Prisons; Private ICE Detention Continues (Filter)

• 5 Athletes Who Healed With Psychedelic Therapy (Benzinga)

• “A ‘Dose’ of Radical Christianity”: Psychedelic Therapy with Dr. Florence Nichols (Chacruna)

• atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents (Psilocybin Alpha)

• Ohio Students Launch Harm Reduction and “Bad Batch” Alerts App (Filter)

• Taking Psychedelics When You’re Not Feeling Good (Maps of the Mind)

• In Brazil, Bolsonaro Continues to Pump Blood to the War on Drugs (TalkingDrugs)

• Inside The Underground World Of Online Psychedelic Support Groups (Benzinga)

• MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category (Psilocybin Alpha)

• How to Start a Career in the Field of Psychedelic Integration (The Third Wave)

• Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market (Psilocybin Alpha)

• Mental Health Issues That Don't Mix Well With Psychedelics (Healing Maps)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.